Table 2.
Group | Dose (mg/kg) | n | TC (mM) | TG (mM) | HDL-C (mM) | LDL-C (mM) | VLDL-C (mM) | FFA (mM) | Amylase (U/L) |
---|---|---|---|---|---|---|---|---|---|
CON | – | 8 | 1.91 ± 0.04 | 0.65 ± 0.03 | 2.21 ± 0.05 | 0.46 ± 0.02 | 11.71 ± 0.66 | 926.44 ± 28.47 | 2,307.12 ± 128.36 |
CON + RES | 15 | 5 | 1.94 ± 0.02## | 0.64 ± 0.02# | 2.12 ± 0.06## | 0.43 ± 0.02## | 10.20 ± 0.52 | 947.80 ± 24.38 | 2,345.00 ± 118.06 |
NAFLD | – | 8 | 2.51 ± 0.05** | 0.74 ± 0.03* | 1.76 ± 0.02** | 0.78 ± 0.02** | 10.52 ± 0.26 | 893.57 ± 15.62 | 2,210.25 ± 101.61 |
NAFLD + RES | 15 | 8 | 1.90 ± 0.04## | 0.69 ± 0.02 | 2.01 ± 0.04## | 0.54 ± 0.02## | 12.10 ± 0.40 | 933.53 ± 22.59 | 2,238.62 ± 72.91 |
NAFLD + STG | 10 | 8 | 1.98 ± 0.04## | 0.66 ± 0.02 | 2.01 ± 00.03## | 0.52 ± 0.02## | 13.53 ± 1.04 | 913.97 ± 20.18 | 2,255.25 ± 62.34 |
NAFLD + RSG | 5 | 8 | 2.01 ± 0.02## | 0.65 ± 0.03# | 2.00 ± 0.03## | 0.51 ± 0.03## | 10.19 ± 0.40 | 877.79 ± 12.07 | 2,265.44 ± 66.23 |
NAFLD + FLX | 2 | 8 | 2.51 ± 0.05 | 0.75 ± 0.04 | 1.74 ± 0.03 | 0.74 ± 0.03 | 13.51 ± 0.87 | 907.73 ± 16.74 | 2,102.12 ± 64.48 |
NAFLD + DNP | 1 | 8 | 2.44 ± 0.06 | 0.66 ± 0.04 | 1.82 ± 0.04 | 0.78 ± 0.02 | 10.94 ± 0.64 | 921.20 ± 20.54 | 2,038.12 ± 140.68 |
P < 0.05 and
P < 0.001 compared with the CON group;
P < 0.05 and
P < 0.001 compared with the NAFLD model group.